Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42

Int Psychogeriatr. 2010 Jun;22(4):598-606. doi: 10.1017/S1041610210000335. Epub 2010 Mar 26.

Abstract

Background: The epsilon4 allele of the apolipoprotein E (APOE) gene and low levels of cerebrospinal fluid (CSF) amyloid beta-proteins 42 (Abeta) have previously been associated with increased risk of cognitive decline in old age. In this study we examine the interaction of these markers with episodic memory in a sample identified as having mild cognitive impairment (MCI).

Methods: The sample (N = 149) was drawn from the Gothenburg MCI study and measured according to three free recall tests on three occasions spanning over four years. Second-order Latent Curve Models (LCM) were fitted to the data.

Results: Analyses accounting for age, gender, education, APOE, Abeta42, and interaction between APOE and Abeta42 revealed that the epsilon4 allele was significantly associated with level of memory performance in the presence of low Abeta42 values (< or = 452 ng/L). Associations between memory performance and Abeta42 were significant among the epsilon4 carriers but not among the non-carriers. The Abeta42 marker was, however, significantly associated with changes in memory over the study time period in the total sample.

Conclusion: The findings support the hypothesis of an interactive effect of APOE and Abeta42 for memory decline in MCI patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Amyloid beta-Peptides / genetics*
  • Apolipoprotein E4 / cerebrospinal fluid*
  • Apolipoprotein E4 / genetics*
  • Chromosomes, Human, Pair 19 / genetics
  • Cognition Disorders / diagnosis
  • Cognition Disorders / epidemiology*
  • Cognition Disorders / genetics*
  • Female
  • Humans
  • Male
  • Memory Disorders / epidemiology*
  • Memory Disorders / genetics*
  • Middle Aged
  • Neuropsychological Tests
  • Peptide Fragments / cerebrospinal fluid*
  • Peptide Fragments / genetics*
  • Severity of Illness Index

Substances

  • Amyloid beta-Peptides
  • Apolipoprotein E4
  • Peptide Fragments
  • amyloid beta-protein (1-42)